Mahmoud S. Abdallah, Esraa M. Mosalam, Ahmed Hassan et Ahmed N. Ramadan, « Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double-blind, randomized, placebo-controlled trial », CNS neuroscience & therapeutics, (ISSN1755-5949, PMID36341700, DOI10.1111/cns.14010, lire en ligne, consulté le )
issn.org
portal.issn.org
Mahmoud S. Abdallah, Esraa M. Mosalam, Ahmed Hassan et Ahmed N. Ramadan, « Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double-blind, randomized, placebo-controlled trial », CNS neuroscience & therapeutics, (ISSN1755-5949, PMID36341700, DOI10.1111/cns.14010, lire en ligne, consulté le )
nih.gov
ncbi.nlm.nih.gov
Mahmoud S. Abdallah, Esraa M. Mosalam, Ahmed Hassan et Ahmed N. Ramadan, « Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double-blind, randomized, placebo-controlled trial », CNS neuroscience & therapeutics, (ISSN1755-5949, PMID36341700, DOI10.1111/cns.14010, lire en ligne, consulté le )
pubmed.ncbi.nlm.nih.gov
Mahmoud S. Abdallah, Esraa M. Mosalam, Ahmed Hassan et Ahmed N. Ramadan, « Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double-blind, randomized, placebo-controlled trial », CNS neuroscience & therapeutics, (ISSN1755-5949, PMID36341700, DOI10.1111/cns.14010, lire en ligne, consulté le )